2型糖尿病大鼠心肌脂肪酸转运体FAT/CD36的表达变化及其对脂肪酸代谢的影响
被引量:2
Change of myocardium FAT/CD36 expression in rats with type 2 diabete and its influence on fatty acid metabolism
摘要
在心血管疾病的众多危险因素中,糖尿病日益受到人们的重视。糖尿病时高血糖、高胰岛素及血脂异常可加重冠状动脉硬化的程度,增高冠心病的发病率,同时糖尿病亦是非缺血性心力衰竭的重要病因。
出处
《第二军医大学学报》
CAS
CSCD
北大核心
2010年第5期576-578,共3页
Academic Journal of Second Military Medical University
参考文献10
-
1Yang Y K,Chen M,Clements R H,Abrams G A,Aprahamian C J, Harmon C M. Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes[J]. Cell Physiol Bioehem, 2008,22 (5-6) : 531-538.
-
2Srinivasan K, Viswanad B, Asrat L, Kaul C L, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocintreated rat: a model for type 2 diabetes and pharmacological screening[J]. Pharmacol Res, 2005,52 : 313-320.
-
3Hajri T, Abumrad N A. Fatty acid transport across membranes: relevance to nutrition and metabolic pathology[J]. Annu Rev Nutr, 2002,22: 383-415.
-
4Carley A N,Atkinson L L,Bonen A, Harper M E,Kunnathu S, Lopaschuk G D, et al. Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice[J]. Arch Physiol Biochem,2007,113:65-75.
-
5Han X X, Chabowski A, Tandon N N, Calles-Escandon J, Glatz J F, Luiken J J,et al. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FAB- Ppm in obese Zucker rat muscle[J]. Am J Physiol Endocrinol Metab, 2007,293 : E566-E575.
-
6Cook G A,Edwards T L,Jansen M S,Bahouth S W,Wilcox H G,Park E A. Differential regulation of carnitine palmitoyltrans ferase-I gene isoforms (CPT-I alpha and CPT I beta) in the rat heart[J]. J Mol Cell Cardiol,2001,33: 317-329.
-
7Holloway G P,Luiken J J,Glatz J F,Spriet L L,Bonen A. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview[J].Acta Physiol (Oxf), 2008, 194 : 293-309.
-
8Heilbronn L K,Gregersen S,Shirkhedkar D, Hu D,Campbell L V. Impaired fat oxidation after a single high fat meal in insulin- sensitive nondiabetie individuals with a family history of type 2 diabetes[J].Diabetes, 2007,56 : 2046-2053.
-
9Bonen A, Hollow~ay G P, Tandon N N, Han X X, McFarlan J, Glatz J F,et al. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats[J]. Am J Physiol Regul Integr Comp Physiol, 2009,297 : R1202-R1212.
-
10Carley A N, Severson D L. What are the biochemical mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice[J].Cardiovasc Drugs Ther, 2008,22: 83-89.
同被引文献17
-
1陈松娥,彭峰林,邓树勋.有氧耐力训练对大鼠心脏机能和心肌脂肪酸氧化酶基因表达的影响[J].体育科学,2006,26(12):70-72. 被引量:5
-
2Aneja A, Tang WH, Bansilal S, et al. Diabetic cardiomyopa- thy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med. 2008, 121(9):748-757.
-
3Boudina S, Abel ED. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord. 2010, 11(1) :31-39.
-
4Boudina S, Abel ED. Diabetic eardiomyopathy revisited. Cir- culation. 2007,115 (25) : 3213-3223.
-
5Avogaro A, Vigili de Kreutzenberg S, Negut C, et al. Dia- betic cardiomyopathy: a metabolic perspective. AmJ Cardiol. 2004, 93(8A) :13A-16A.
-
6An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2006, 291(4) :H1489-1506.
-
7Barger PM, Kelly DP. PPAR signaling in the control of cardi- ac energy metabolism. Trends Cardiovasc Med. 2000, 10(6) : 238-245.
-
8Holness MJ, Samsuddin S, Sugden MC. The role of PPARs in modulating cardiac metabolism in diabetes. Pharmacol Res. 2009, 60(3) :185-194.
-
9Yang Q, Li Y. Roles of PPARs on regulating myocardial energy and lipid homeostasis. J Mol Med. 2007, 85(7):697-706.
-
10Baranowski M, Blachnio-Zabielska A, Gorski J. Peroxisome proliferator-activated receptor alpha activation induces un- favourable changes in fatty acid composition of myocardial phospholipids. J Physiol Pharmacol. 2009: 60(2) : 13-20.
二级引证文献9
-
1王兰兰,漆欣,李菊莲.代谢组学在肥胖症中的研究进展[J].生命的化学,2018,38(6):803-808. 被引量:4
-
2付乐,张蕴琨.运动与过氧化物酶体增殖物激活受体-α的研究进展[J].南京体育学院学报(自然科学版),2015,14(2):39-43. 被引量:2
-
3曾友美.超重女性有氧运动对红细胞代谢的影响作用[J].科学技术与工程,2016,16(23):129-133. 被引量:3
-
4蔡欢,何玉秀.运动对PPARs及糖尿病心肌病糖代谢和脂肪代谢紊乱的影响[J].中国运动医学杂志,2016,35(11):1056-1060. 被引量:11
-
5李正洪.有氧运动对青少年骨骼肌细胞葡萄糖氧化代谢的影响[J].科学技术与工程,2017,17(6):142-146. 被引量:1
-
6周儆劼.L-肉碱联合有氧运动对肥胖小鼠脑酮体代谢的影响[J].南京体育学院学报(自然科学版),2017,16(3):58-60. 被引量:4
-
7彭丽娜,赵艳薇,彭丽研.L-肉碱对NAFLD脂肪肝大鼠肝脏线粒体能量代谢及抗氧化能力的影响[J].生物医学工程研究,2017,36(3):258-261. 被引量:3
-
8孙易,张怡,丁树哲.跑台运动对db/db小鼠心肌PPARα信号通路的影响研究[J].中国体育科技,2023,59(4):67-76.
-
9李宸涵,张伟,王盼盼,张鹏飞,安冏,杨红燕,高峰,武桂铃,张星.生酮饮食通过上调肝脏和棕色脂肪组织PPARα提高小鼠耐低温能力[J].生理学报,2023,75(2):171-178.
-
1李全忠.CD36抗原与动脉粥样硬化[J].中国动脉硬化杂志,1999,7(1):82-84. 被引量:2
-
2陈俊华,张向阳.CD36抗原在动脉粥样硬化发生机制中的作用[J].心血管病学进展,2008,29(5):795-798. 被引量:7
-
3白玲,马爱群,雷新军,吴格如,白晓君.抗磷脂抗体对巨噬细胞摄取氧化型低密度脂蛋白及CD36表达的影响[J].中国动脉硬化杂志,2002,10(6):499-501. 被引量:3
-
4刘瑞,马爱群,郝春媛,刘进军,高广道.单核细胞与内皮细胞的相互作用对单核细胞CD36表达的影响[J].中国病理生理杂志,2004,20(3):351-353. 被引量:1
-
5曾蓉,严新民,宋滇平,高建梅.2型糖尿病患者FAT/CD36基因启动子区-3489C/T和密码子区478C/T多态性研究[J].中华临床医师杂志(电子版),2008,2(3):16-19. 被引量:1
-
6袁海瑞,牛燕媚,傅力.脂肪酸转位酶(FAT/CD36)在运动改善胰岛素抵抗中的作用[J].中国运动医学杂志,2010,29(6):718-721. 被引量:7
-
7程梭梭,袁莉.CD36与脂肪酸代谢和胰岛素抵抗[J].国际内分泌代谢杂志,2010,30(1):38-40. 被引量:2
-
8杨骄霞,徐晶,王媛媛,郭继芳,吕恒娟,乔智力.阿托伐他汀对病毒性心肌病心力衰竭小鼠脂肪酸代谢变化的研究[J].中国药物与临床,2012,12(7):892-893.
-
9楼望,伊木清,李伟军,胥靓,周丽丽,许葆华,高红,付劲德.耐力训练大鼠骨骼肌FAT/CD36表达及其与胰岛素敏感性的相关分析[J].中国运动医学杂志,2010,29(2):177-180.
-
10李燕,陈璐璐,王咏波,田源.高糖高脂对β细胞脂肪酸转位酶基因表达的影响[J].中国现代医学杂志,2007,17(24):2979-2982.